SCHEMBL2666495

SCHEMBL2666495

COC(=O)CCNC(=O)c1ccc(COc2cc(C)c(-c3ccc(C(C)(C)C)cc3)c(C)c2)s1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GCGR P47871 2/20 0.44
MEN1 O00255 2/20 0.37
KMT2A Q03164 2/20 0.37
ACKR3 P25106 1/20 0.37
L3MBTL1 Q9Y468 2/20 0.37
FFAR1 O14842 1/20 0.37
VDR P11473 1/20 0.36
PPARD Q03181 1/20 0.36
NPC1 O15118 2/20 0.35
RAB9A P51151 2/20 0.35
POLB P06746 1/20 0.35
CASP3 P42574 1/20 0.35
SENP7 Q9BQF6 1/20 0.35
MRGPRX4 Q96LA9 1/20 0.35
ESRRB O95718 1/20 0.35
ESRRG P62508 1/20 0.35
MAPT P10636 2/20 0.35
SMN1; SMN2 Q16637 1/20 0.34
CYP1A2 P05177 1/20 0.34
CYP3A4 P08684 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2666428 0.92 GCGR (0.40) GCGRFFAR1PPARDMAPT
SCHEMBL2653964 0.92 GCGR (0.53) GCGRMEN1KMT2AACKR3L3MBTL1
SCHEMBL2654238 0.91 GCGR (0.43) GCGRMEN1KMT2AACKR3L3MBTL1
SCHEMBL2653812 0.90 GCGR (0.42) GCGRMEN1KMT2AACKR3VDR
SCHEMBL2652386 0.89 GCGR (0.42) GCGRMEN1KMT2AACKR3L3MBTL1
SCHEMBL2654307 0.89 HPGD (0.43) GCGRMEN1KMT2AACKR3L3MBTL1
SCHEMBL2653233 0.88 GCGR (0.43) GCGRMEN1KMT2AACKR3L3MBTL1
SCHEMBL2654872 0.85 GCGR (0.42) GCGRMEN1KMT2AACKR3L3MBTL1
SCHEMBL13647290 0.83 GCGR (0.44) GCGRMEN1KMT2AACKR3L3MBTL1
SCHEMBL2666451 0.83 GCGR (0.48) GCGRFFAR1PPARD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2006086488-A2 SUBSTITUTED THIOPHENE DERIVATIVES AS GLUCAGON RECEPTOR ANTAGONISTS, PREPARATION AND THERAPEUTIC USES ELI LILLY AND COMPANY (US) 2006-08-17 WO disclosed